Vaxart, Inc.
Biotechnology company · South San Francisco, California, United States · OTC: VXRT
Vaxart, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its shares trade on OTC under the ticker VXRT. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2009. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2013.
What does Vaxart do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2007 to 2009).
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $20 million sold (2013).
Frequently asked questions about Vaxart
Where is Vaxart headquartered?
Vaxart, Inc. is headquartered in South San Francisco, California, United States.
What does Vaxart do?
Vaxart, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Vaxart a public company?
Yes. Vaxart, Inc. trades on OTC under the ticker VXRT.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
- Electra Therapeutics, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.